LIFETECH SCI(01302),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01302 LIFETECH SCI

Pre-opening 12-23 09:29:37

1.580

+0.000

0.00%

High1.580	Low1.580	Vol2.00K
Open1.580	D1 Closing1.580	Amplitude0.00%
Mkt Cap7.32B	Tradable Cap7.32B	Total Shares4.63B
T/O3.16K	T/O Rate0.00%	Tradable Shares4.63B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01302","market":"HK","secType":"STK","nameCN":"LIFETECH SCI","latestPrice":1.58,"timestamp":1766452819632,"preClose":1.58,"halted":0,"volume":2000,"delay":0,"floatShares":4632000000,"shares":4632000000,"eps":0.05617975474868156,"marketStatus":"Pre-opening","change":0,"latestTime":"12-23 09:29:37","open":1.58,"high":1.58,"low":1.58,"amount":3160,"amplitude":0,"askPrice":1.58,"askSize":8000,"bidPrice":1.57,"bidSize":62000,"shortable":3,"etf":0,"ttmEps":0.01832499276613618,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766453400000},"marketStatusCode":1,"adr":0,"listingDate":1320854400000,"exchange":"SEHK","adjPreClose":1.58,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01302/tweets","defaultTab":"tweets","newsList":[{"id":"1120162120","title":"LIFETECH SCI (01302) Shareholder Transfers Shares from CCB International Securities to Futu Securities International (Hong Kong) with Transfer Value of HK$407 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120162120","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120162120?lang=en_us&edition=fundamental","pubTime":"2025-12-15 08:20","pubTimestamp":1765758012,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange reveals that on December 12, a shareholder of LIFETECH SCI (01302) transferred shares from CCB International Securities to Futu Securities International...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","01302","BK1583","BK1600","BK1100"],"gpt_icon":0},{"id":"2590377490","title":"LifeTech Scientific Trustee to Buy Back Shares Worth HK$437 Million; Shares Plunge 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377490","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377490?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:17","pubTimestamp":1765340279,"startTime":"0","endTime":"0","summary":"LifeTech Scientific's  trustee agreed to acquire 230 million shares from substantial shareholder Xianjian Advanced Technology for HK$437 million or HK$1.90 apiece, a Tuesday Hong Kong bourse filing said.Shares of the medical device manufacturer were down over 9% in Wednesday afternoon trading.The shares will be purchased using funding to be provided by the firm for the share award scheme.The seller, currently holding a 14.99% stake in LifeTech Scientific, will own 464.2 million, or 10.02%, of the latter's issued shares on completion, which is expected Dec. 12.Xianjian Advanced Technology is wholly owned by Xie Yuehui, LifeTech Scientific's chairman and CEO.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","01302","BK1583","BK1600"],"gpt_icon":0},{"id":"1192157837","title":"LIFETECH SCI (01302): Trustee Purchases 230 Million Shares Under Share Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1192157837","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192157837?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:26","pubTimestamp":1765283179,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) announced that on December 9, 2025, the trustee, Futu Trustee Limited, the seller Xianjian Advanced Technology Limited, and the company entered into an agreement. Under the share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1600","01302","BK1583"],"gpt_icon":0},{"id":"1120832967","title":"LifeTech Scientific (01302) Announces Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1120832967","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120832967?lang=en_us&edition=fundamental","pubTime":"2025-12-02 16:46","pubTimestamp":1764665217,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation released its monthly return for equity securities as of November 30, 2025. According to the announcement, the company’s total authorized share capital remained at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"gpt_icon":0},{"id":"2587791402","title":"Assessing LifeTech Scientific (SEHK:1302) Valuation Following Latest Board and Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2587791402","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587791402?lang=en_us&edition=fundamental","pubTime":"2025-11-30 13:18","pubTimestamp":1764479884,"startTime":"0","endTime":"0","summary":"LifeTech Scientific (SEHK:1302) has unveiled a wave of board and leadership changes, highlighted by the appointment of Ms. Chen Dongxia as Independent Non-executive Director. Several seasoned executives are also joining the management team.\nSee our latest analysis for LifeTech Scientific.\nLifeTech Scientific’s stock has caught the market’s attention recently, with a year-to-date share price return of 40.15%. This reflects renewed optimism following this fresh leadership lineup. While the last...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/assessing-lifetech-scientific-sehk1302-valuation-following-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/assessing-lifetech-scientific-sehk1302-valuation-following-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01302","BK1600","DCF","BK1100","BK1583"],"gpt_icon":0},{"id":"2585817142","title":"BRIEF-LifeTech Scientific Says Ruan Xingmei Resigns As Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2585817142","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585817142?lang=en_us&edition=fundamental","pubTime":"2025-11-21 23:59","pubTimestamp":1763740799,"startTime":"0","endTime":"0","summary":"BRIEF-LifeTech Scientific Says Ruan Xingmei Resigns As Executive DirectorNov 21  - LifeTech Scientific Corp 1302.HK:RUAN XINGMEI RESIGNS AS EXECUTIVE DIRECTORWU LIPING AND FANG YU APPOINTED AS EXECUTIVE DIRECTORSFENG XIAOLING APPOINTED AS EXECUTIVE DIRECTORFurther company coverage: 1302.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","01302","BK1583","BK1100"],"gpt_icon":0},{"id":"1108399535","title":"LIFETECH SCI (01302): Chen Dongxia Appointed as Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1108399535","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108399535?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:36","pubTimestamp":1763735790,"startTime":"0","endTime":"0","summary":"Effective November 21, 2025, LIFETECH SCI (01302) announced the following changes to its board and committees: - Ms. Ruan Xingmei has resigned as an executive director and member of the nomination...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","01302","BK1100","BK1583"],"gpt_icon":0},{"id":"2585149358","title":"LifeTech Scientific Corporation Files Director List with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2585149358","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585149358?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:26","pubTimestamp":1763735170,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The Board is led by Xie Yuehui, who serves as Chairman and Chief Executive Officer. Other executive directors include Liu Jianxiong , Wu Liping, Fang Yu, and Feng Xiaoling. Jiang Feng serves as a non-executive director. The independent non-executive directors are Wang Wansong, Zhou Luming, and Chen Dongxia. The company has established three Board committees. The Audit Committee is chaired by Chen Dongxia, with Zhou Luming and Wang Wansong as members. The Remuneration Committee is chaired by Wang Wansong, with Xie Yuehui and Chen Dongxia as members. The Nomination Committee is chaired by Zhou Luming, with Xie Yuehui, Feng Xiaoling, Wang Wansong, and Chen Dongxia as members.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL6RVrVy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1600","01302","BK1583"],"gpt_icon":0},{"id":"2585714602","title":"LifeTech Scientific - Ruan Xingmei Resigns as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2585714602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585714602?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:21","pubTimestamp":1763734866,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1583","01302","BK1100"],"gpt_icon":0},{"id":"2585460791","title":"LifeTech Scientific - Wu Liping and Fang Yu Appointed as Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2585460791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585460791?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:21","pubTimestamp":1763734866,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX10I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1100","01302","BK1583"],"gpt_icon":0},{"id":"2585146075","title":"LifeTech Scientific - Feng Xiaoling Appointed as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2585146075","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585146075?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:21","pubTimestamp":1763734866,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX10I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1583","01302","BK1100"],"gpt_icon":0},{"id":"2583750213","title":"LifeTech Scientific (SEHK:1302): Valuation Insights Following China Approval of G-BranchTM Stent Graft System","url":"https://stock-news.laohu8.com/highlight/detail?id=2583750213","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583750213?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:21","pubTimestamp":1763126495,"startTime":"0","endTime":"0","summary":"LifeTech Scientific (SEHK:1302) has received official approval from the China National Medical Products Administration for its G-BranchTM thoracoabdominal artery stent graft system. This marks a major regulatory milestone for the company and its medical device portfolio.\nSee our latest analysis for LifeTech Scientific.\nEven with this breakthrough regulatory approval, LifeTech Scientific’s stock has experienced some choppiness in recent months. While the 1-year total shareholder return sits at...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/lifetech-scientific-sehk1302-valuation-insights-following-ch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/lifetech-scientific-sehk1302-valuation-insights-following-ch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1100","BK1600","BK1583","DCF","01302"],"gpt_icon":0},{"id":"1192583551","title":"LIFETECH SCI (01302): G-BranchTM Thoracoabdominal Aortic Stent Graft System Receives Official Registration Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1192583551","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192583551?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:00","pubTimestamp":1762434019,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) announced that on November 6, 2025, the G-BranchTM Thoracoabdominal Aortic Stent Graft System (G-BranchTM or the Product), jointly developed by Professor Guo Wei's team from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1100","BK1583","01302"],"gpt_icon":0},{"id":"2581709892","title":"LifeTech Scientific Wins China NMPA Approval for G-Branch Thoracoabdominal Artery Stent Graft System","url":"https://stock-news.laohu8.com/highlight/detail?id=2581709892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581709892?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:50","pubTimestamp":1762433436,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation has announced that its G-Branch Thoracoabdominal Artery Stent Graft System has received official registration approval from the China National Medical Products Administration . This approval follows the earlier launch of the company's Aortic Arch Stent Graft System and Aortic Stent Graft System in the first half of 2025, further expanding LifeTech's portfolio in peripheral vascular intervention. With this milestone, LifeTech becomes one of the first innovative companies to offer integrated endovascular aortic repair solutions globally. The company plans to continue advancing and commercializing new medical device products to address urgent clinical needs. No grant or funding from multiple organizations was mentioned in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL5dyFKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1600","01302"],"gpt_icon":0},{"id":"2581209866","title":"LifeTech Scientific - G-Branch Thoracoabdominal Artery Stent Graft System Approved by China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2581209866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581209866?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:46","pubTimestamp":1762433215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI1PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01302","BK1600","BK1583","BK1100"],"gpt_icon":0},{"id":"1159273629","title":"LifeTech Scientific (01302) Announces October 2025 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1159273629","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159273629?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:52","pubTimestamp":1762332771,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation (01302) released its October 2025 Monthly Return, highlighting no changes in authorized or issued share capital compared to the previous month. The authorized share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"gpt_icon":0},{"id":"1133753951","title":"LIFETECH SCI (01302) Announces Two-Year Follow-Up Results of Phase II and Phase III Clinical Studies for IBS® Bioabsorbable Drug-Eluting Coronary Stent System","url":"https://stock-news.laohu8.com/highlight/detail?id=1133753951","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133753951?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:40","pubTimestamp":1761738042,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) announced that its self-developed IBS® bioabsorbable drug-eluting coronary stent system has successfully completed Phase II clinical studies and two-year follow-up for Phase III...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","BK1100","III","01302","BK1600","BK1583"],"gpt_icon":0},{"id":"1112481962","title":"LifeTech Scientific Corporation (1302) Releases Two-Year Follow-Up Clinical Results for IBS® Coronary Scaffold","url":"https://stock-news.laohu8.com/highlight/detail?id=1112481962","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112481962?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:25","pubTimestamp":1761737106,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation (1302) has published comprehensive two-year follow-up findings from its Phase II and Phase III clinical studies evaluating the self-developed IBS® Sirolimus-Eluting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"gpt_icon":0},{"id":"2579197299","title":"LifeTech Scientific Reports Two-Year Clinical Results for IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold","url":"https://stock-news.laohu8.com/highlight/detail?id=2579197299","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579197299?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:13","pubTimestamp":1761736388,"startTime":"0","endTime":"0","summary":"LifeTech Scientific Corporation has announced the publication of two-year follow-up results from its Phase II and Phase III clinical studies of the IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System. According to the announcement, the follow-up data from these clinical studies have been submitted to the National Medical Products Administration  and to the European Union for CE registration approval. The company states that these results further enhance the evidence base for the IBS Coronary Scaffold and are expected to support its global development. The results have already been presented and submitted to relevant regulatory authorities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeTech Scientific Corporation publ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL3kRNw0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01302","BK1100","BK1600"],"gpt_icon":0},{"id":"2576026548","title":"Can Mixed Fundamentals Have A Negative Impact on LifeTech Scientific Corporation (HKG:1302) Current Share Price Momentum?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576026548","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576026548?lang=en_us&edition=fundamental","pubTime":"2025-10-19 08:19","pubTimestamp":1760833160,"startTime":"0","endTime":"0","summary":"Most readers would already be aware that LifeTech Scientific's (HKG:1302) stock increased significantly by 12% over the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/can-mixed-fundamentals-have-a-negative-impact-on-lifetech-sc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1302/lifetech-scientific-shares/news/can-mixed-fundamentals-have-a-negative-impact-on-lifetech-sc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1600","01302","BK1583","BK1100"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifetechmed.com","stockEarnings":[{"period":"1week","weight":0.0327},{"period":"1month","weight":-0.1459},{"period":"3month","weight":-0.1319},{"period":"6month","weight":-0.198},{"period":"1year","weight":0.0748},{"period":"ytd","weight":0.1367}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"LifeTech Scientific Corp is an investment holding company primarily engaged in the development, manufacture and trading of interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company mainly operates its business through three segments. The Structural Heart Diseases Business segment is engaged in trading, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in trading, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment is engaged in trading, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.012746},{"month":2,"riseRate":0.416667,"avgChangeRate":0.039224},{"month":3,"riseRate":0.583333,"avgChangeRate":0.016941},{"month":4,"riseRate":0.5,"avgChangeRate":0.003601},{"month":5,"riseRate":0.583333,"avgChangeRate":0.097774},{"month":6,"riseRate":0.583333,"avgChangeRate":0.059054},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.066814},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049509},{"month":9,"riseRate":0.583333,"avgChangeRate":0.031147},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004062},{"month":11,"riseRate":0.416667,"avgChangeRate":0.043537},{"month":12,"riseRate":0.384615,"avgChangeRate":0.001365}],"exchange":"SEHK","name":"LIFETECH SCI","nameEN":"LIFETECH SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LIFETECH SCI(01302),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LIFETECH SCI(01302) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LIFETECH SCI,01302,LIFETECH SCI股票,LIFETECH SCI股票老虎,LIFETECH SCI股票老虎国际,LIFETECH SCI行情,LIFETECH SCI股票行情,LIFETECH SCI股价,LIFETECH SCI股市,LIFETECH SCI股票价格,LIFETECH SCI股票交易,LIFETECH SCI股票购买,LIFETECH SCI股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LIFETECH SCI(01302),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LIFETECH SCI(01302) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}